1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akebia Therapeutics Inc (AKBA)

  7. Akebia Therapeutics Inc (AKBA) News

AKBA

Akebia Therapeutics Inc
0.64
-0.0454 (-6.62%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Akebia Therapeutics Inc AKBA NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
-0.0454 -6.62% 0.64 08:27:12
Open Price Low Price High Price Close Price Previous Close
0.69 0.613 0.69 0.6388 0.6854
more quote information »

Recent News

Date Time Source Heading
24/3/202323:40EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
24/3/202323:30PRNUSAkebia Therapeutics Files Revised Definitive Proxy Statement..
11/3/202308:29EDGARAnnual Report (10-k)
09/3/202323:30PRNUSAkebia Therapeutics Reports Fourth Quarter and Full-Year..
04/3/202300:02EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202300:02EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202300:02EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202300:01EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202300:01EDGARStatement of Changes in Beneficial Ownership (4)
03/3/202308:07EDGARCurrent Report Filing (8-k)
03/3/202300:30PRNUSAkebia Therapeutics to Report Fourth Quarter and Full-Year..
02/3/202308:08EDGARStatement of Changes in Beneficial Ownership (4)
02/3/202308:08EDGARStatement of Changes in Beneficial Ownership (4)
02/3/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
02/3/202308:07EDGARProxy Statement (definitive) (def 14a)
02/3/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
24/2/202308:05PRNUSAkebia Receives Positive CHMP Opinion in Europe for Vafseo™..
21/2/202322:52EDGARCurrent Report Filing (8-k)
21/2/202322:30PRNUSAkebia Therapeutics Received Interim Response from the FDA..
11/2/202305:09EDGARAmended Statement of Ownership (sc 13g/a)
10/2/202302:59EDGARAmended Statement of Ownership (sc 13g/a)
02/2/202308:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
31/1/202308:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
21/1/202300:55EDGARAmended Statement of Ownership (sc 13g/a)
10/1/202300:32EDGARCurrent Report Filing (8-k)
04/1/202308:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
29/12/202200:16EDGARCurrent Report Filing (8-k)
23/12/202200:45PRNUSAkebia Therapeutics Received Interim Response to Appeal for..
20/12/202208:11EDGARStatement of Ownership (sc 13g)
14/12/202208:04EDGARConfidential Treatment Order (ct Order)
03/12/202208:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
23/11/202208:05PRNUSAkebia Therapeutics to Participate in the Piper Sandler 34th..
11/11/202208:10EDGARCurrent Report Filing (8-k)
09/11/202208:08EDGARCurrent Report Filing (8-k)
04/11/202221:35TRMNH.C. Wainwright Keeps Their Hold Rating on Akebia..
04/11/202207:41EDGARQuarterly Report (10-q)
04/11/202207:35EDGARCurrent Report Filing (8-k)
04/11/202207:05PRNUSAkebia Therapeutics Reports Third Quarter 2022 Financial..
03/11/202207:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
27/10/202223:30PRNUSAkebia Therapeutics to Report Third Quarter Financial..
21/10/202223:30PRNUSAkebia Therapeutics Announces Poster Presentation at ASN..
08/10/202203:27EDGARConfidential Treatment Order (ct Order)
04/10/202207:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
03/9/202206:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02/9/202206:16EDGARStatement of Changes in Beneficial Ownership (4)
01/9/202222:30PRNUSAkebia Therapeutics to Present Virtually at the H.C...
05/8/202221:45TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SQZ..
05/8/202220:38TRMNH.C. Wainwright Maintains a Hold Rating on Akebia..
05/8/202206:16EDGARCurrent Report Filing (8-k)
05/8/202206:05PRNUSAkebia Therapeutics Reports Second Quarter 2022 Financial..
Your Recent History
NASDAQ
AKBA
Akebia The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230326 15:02:42